The gap between trailing P/E of 43.79 and forward P/E of 20.60 suggests the market is pricing in an earnings recovery that depends on margins stabilizing after the decline from 27.5% gross margin in 2024Q2 to 22.6% in 2026Q3. A PEG near 10 indicates the current price implies growth well beyond what recent quarterly revenue trends support, which warrants investor scrutiny. EV/EBITDA of 16.94 versus 13.39 forward implies similar expectations of earnings improvement.

The decline in operating margin outpaces the gross margin decline, pointing to rising SG&A absorbing gross profit gains and reducing operating leverage. Net margin of 3.3% leaves little cushion against further cost pressure, and quarterly swings including a net loss in 2025Q1 make the underlying earning power difficult to isolate. Operating margin is the more reliable gauge of true earning power here, since net income is distorted by amortization and integration costs.

ROIC decay tracks the margin compression rather than any deterioration in asset turnover, which has held near 0.13 to 0.14. Because goodwill represents roughly one-third of the asset base, reported returns are structurally diluted by acquisition capital. Investors should monitor whether returns recover toward 2024 levels or continue to erode as acquisition-driven capital remains embedded in the denominator.

The moderate leverage ratio appears comfortable on its face, yet the interest coverage collapse in 2025Q1 reflects how thin operating income can become relative to fixed financing costs in weaker quarters. Debt-to-EBITDA near 21 in the latest quarter, though elevated, is driven by compressed trailing EBITDA rather than rising debt. Refinancing risk cannot be assessed from the supplied data alone and should be treated as an open question.